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Objective: In order to gain a better understanding of the timing of emergent symptoms of osteoarthritis,
we sought to investigate the existence, duration and nature of a prodromal symptomatic phase pre-
ceding incident radiographic knee osteoarthritis (ROA).
Design: Data were from the incidence cohort of the Osteoarthritis Initiative (OAI) public use datasets.
Imposing a nested caseecontrol design, ten control knees were selected for each case of incident
tibiofemoral ROA between 2004 and 2010 from participants aged 45e79 years. Candidate prodromal
symptoms were Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) and Knee
injury and Osteoarthritis Outcome Score (KOOS) subscale scores and individual items, available up to 4
years prior to the time of incident ROA. Multi-level models were used to estimate the length of the
prodromal phases.
Results: The prodromal phase for subscale scores ranged from 29 months (KOOS Other Symptoms) to 37
months (WOMAC Pain). Pain and difﬁculty on activities associated with higher dynamic knee loading
were associated with longer prodromal phases (e.g., pain on twisting/pivoting (39 months, 95% conﬁ-
dence interval: 13, 64) vs pain on standing (25 months: 7, 42)).
Conclusions: Our analysis found that incident ROA is preceded by prodromal symptoms lasting at least 2
e3 years. This has potential implications for understanding phasic development and progression of
osteoarthritis and for early recognition and management.
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Osteoarthritis has a substantial impact on the health of in-
dividuals and populations worldwide1,2. Symptoms often precede
the appearance on plain radiographs of features traditionally used
to deﬁne disease incidence (e.g., marginal osteophytes, joint space
narrowing)3e5, implying the existence of a potentially detectable
‘prodromal phase’ (period of premonitory symptoms) in the tran-
sition from pre-radiographic to radiographic stages of osteoar-
thritis. In the pre-radiographic stage, magnetic resonance imaging
reveals lesions in articular cartilage, subchondral bone, bone
marrow, and meniscus that appear to be associated withjoca.2015.03.033.
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r Ltd and Osteoarthritis Research Ssymptoms6e8, suggesting a range of plausible sources of pain in this
hypothesised prodromal phase. The investigation of prodromes has
been an important focus for research in several recurrent-relapsing
and chronic long-term conditions9e12 where its signiﬁcance is seen
in terms of the prospects of early intervention, targeted search for
biomarkers, understanding pathogenesis and the process of
developing illness or disease, and enriched sampling for efﬁcient
trial design. These are also major concerns in osteoarthritis
research and our desire to understand the contribution of simple
patient-reported information to these goals was a strong motiva-
tion behind the current study. However, until recently it was not
possible to undertake a prospective investigation of the timing of
symptom changes before the occurrence of gross pathological
changes on radiographs due to the lack of longitudinal studies that
have obtained sufﬁciently frequent repeated images of the joint
and measures of symptoms in persons at risk of developing
radiographic knee osteoarthritis (ROA).
The Osteoarthritis Initiative (OAI) was established in 2001. It is a
nationwide, multi-centre, longitudinal, prospective observational
study of knee osteoarthritis, funded by private-public partnership,ociety International. This is an open access article under the CC BY-NC-ND license
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resource13. In a nested caseecontrol analysis using data from par-
ticipants enrolled between 2004 and 2006 and with annual plain
radiography and measures of symptoms, we hypothesised that the
incidence of ROAwould be preceded by an increase in symptoms in
which the symptoms that were earliest to appear and that had the
strongest association with future incidence would be those expe-
rienced during more demanding activities involving high me-
chanical loads on the knee14.
Methods
Study setting and population
The study population comprises participants of the OAI ‘inci-
dence sub-cohort’15. Between 2004 and 2006, 3,284 persons aged
45e79 years and at high risk of developing ROA were enrolled at 4
recruitment centers (Baltimore, MD; Pawtucket, RI; Columbus, OH;
Pittsburgh, PA) from a combination of focused mailings, websites,
and local advertisements, presentations and meetings. Potential
participants were screened by telephone and clinic visit and were
enrolled in the incidence sub-cohort if they did not have symp-
tomatic ROA in either knee but were at high risk according to the
presence of predetermined age-speciﬁc combinations of known
risk factors (e.g., frequent knee symptoms, overweight, knee sur-
gery). Individuals with an existing diagnosis of rheumatoid arthritis
or other inﬂammatory arthritis were excluded. Extensive data were
collected from participants at enrolment including self-complete
questionnaires, personal interview, physical examination and
plain radiography. Measures are repeated at annual clinic visits
(94%, 89%, 85%, and 80% successfully followed up at 1, 2, 3, and 4
years respectively). All participants signed informed consent, and
the study was approved by the institutional review board. Data
used in the preparation of this article were obtained from the OAI
database, which is available for public access at http://www.oai.
ucsf.edu/. Speciﬁc datasets used were: “enrollees; version 18”,
“outcomes99; version 3”, “allclinical00; version 0.2.2”, “allclin-
ical01; version 1.2.1”, “allclinical03; version 3.2.1”, “allclinical05;
version 5.2.1”, “allclinical06; version 6.2.1”, “physexam00; version
0.2.2”, “physexam01; 1.2.1”, “physexam03; 3.2.1”, “physexam05;
version 5.2.1”, “physexam06; version 6.2.1”, “subjectchar00;
version 0.2.2”, “subjectchar01; version 1.2.1”, “subjectchar03;
version 3.2.1”, “subject char05; version 5.2.1”, “subjectchar06;
version 6.2.1”, “medhist00; version 0.2.2”, “jointsx00; version
0.2.2”, “kxr_sq_bu00; version 0.6”, “kxr_sq_bu01; version 1.6”,
“kxr_sq_bu03; version 3.5”, “kxr_sq_bu05; version 5.5” and
“kxr_sq_bu06; version 6.3”.
Selection of cases and controls
We sampled knees that developed incident ROA during follow-
up up to 4 years, which werewithout knee symptoms onmost days
at enrolment, in order to control for the potential effect of the
control group being entered into the OAI for different ‘at risk’ fac-
tors than the cases. Incident ROA, ascertained from ﬁxed-ﬂexion
knee radiographs repeated at annual visits, was deﬁned as the
new onset of combined deﬁnite osteophyte and joint space nar-
rowing in the tibiofemoral joint16. This outcome deﬁnition is the
same as that used in previous studies investigating early disease
biomarkers17, and has been found to be associated with increased
risk of further future disease progression18. The annual visit at
which incident ROAwas ﬁrst identiﬁed was denoted in our analysis
as time-zero (t0). Initially, the parameter of interest was the inci-
dence rate ratio and so for each case knee, we used concurrent
sampling19 to select 10 control knees, matched for annual visit butnot side (left/right) of the incident knee. Under this approach,
matched odds ratios estimate incidence rate ratios20.
Potential prodromal symptoms
Information on potential prodromal symptoms was available at
each annual visit from twowell-validated and recommended knee-
speciﬁc self-complete questionnaires21: the Western Ontario &
McMaster Universities Osteoarthritis Index (WOMAC LK 3.122) and
the Knee injury and Osteoarthritis Outcome Score (KOOS23). The
WOMACquestionnaire comprises items on Pain on activity (5 items,
summative subscale score 0e20), Stiffness (2 items, 0e8), and
Physical Functioning (17 items, 0e68) with higher scores indicating
more severe problems. The KOOS comprises items, with some
overlapping content with WOMAC, on Pain (9 items), Other Symp-
toms (7 items), Function in Daily Living (17 items), Function in Sport
and Recreation (5 items), and Knee-related Quality of Life (4 items)
which are reverse-scored to provide 0e100 subscale scores with
lower scores indicatingmore severe problems. For bothmeasures all
questions were answered separately for each knee with response
options typically ‘none/mild/moderate/severe/extreme’, and the
timeframe being ‘within the past 7 days’. In our studywe used some
of these subscale scores (WOMAC Pain, Physical Function and Stiff-
ness, and KOOS Pain and Other Symptoms), categorised as 1 if they
had indicated moderate/severe/extreme symptoms on at least 1 of
the individual items in the scale and 0 if not, due to the non-normal
distributionof the subscale scores, aswell as a selectionof individual
items from these measures (dichotomised into none/mild vs mod-
erate/severe/extreme or never/rarely vs sometimes/often/always)
and pain onmost days of themonth in the last 12months, to explore
the nature of prodromal symptoms. The timing of symptom report
was anchored to the timing of incident ROA, i.e., symptoms reported
1, 2, 3, and4yearsbefore incidentROAweredenotedby t0-1, t0-2, t0-
3, and t0-4.
Statistical analysis
All analyseswere completed in Stata/MP 13.1 (Stata Corporation,
TX, USA). The data was set up as survival time data which was then
converted to caseecontrol data using the -sttocc- command. Con-
ditional logistic regression, with standard errors adjusted (clus-
tered sandwich estimator) for the clustering between knees within
the same person, was used to provide initial estimates of the crude
associations between outcome at each time point, i.e., incident
ROA, and either subscale scores or dichotomised items. Subscale
scores and individual items that differed signiﬁcantly (Wald test,
P < 0.05) between cases and controls 1 year before incident ROA,
i.e., t0-1, were considered for further modelling. Multi-level logistic
regression models were then ﬁtted using the -runmlwin- com-
mand24,25 to estimate the trajectories of the probability of scoring
at least 1 item ‘moderate’, ’severe’ or ’extreme’ in each subscale and
the probability of scoring ‘moderate’, ‘severe’, or ’extreme’ for each
individual item in turn over time for cases and controls, as repeated
measures of symptoms were nested within knees and knees were
nested within people. The length of prodromewas estimated as the
time at which the odds ratio equalled unity, i.e., cases had no
increased odds of scoring higher for that subscale/item compared
to controls (see Web Appendix). The probabilities of a case and of a
control scoring moderate, severe or extreme (or sometimes, often
or always) at each time were plotted for each item.
Each model included the same factors: a dummy variable for
caseecontrol status, time of visit before t0 measured continuously
in years, a product term for interaction between caseecontrol
status and time, age measured continuously centred on the mean,
sex and a constant term. Timewas considered as a non-linear effect
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to the subscales and individual items and Restricted Iterative
Generalised Least Squares (RIGLS) estimation was used when
estimating the models in order to obtain unbiased parameter
estimates.
To evaluate how sensitive our ﬁndings were to our approach to
sampling we repeated the above analyses but selected the ﬁrst
incident knee only per case (if both knees were classed as ‘incident’
at the same annual visit, a knee was randomly selected) from the
sample of knees which had recorded incident ROA by the 4 year
follow. Ten control individuals were sampled for each case from
those who did not develop incident knee ROA in either knee at any
point during the 4-year follow-up. The particular knee for each
control was selected at random, using random number generation.
Multi-level models were then ﬁtted to the data for the subscale
scores only, with the repeated observations at level 1 and the in-
dividual knees at level 2. The results were compared to those
estimated from concurrent sampling.
Results
Patient characteristics
169 knees from 161 persons satisfying the criteria for devel-
oping incident ROA during the ﬁrst 4 years of follow-up of the OAI
cohort were selected (68, 31, 47 and 23 knees at years 1, 2, 3 and 4
respectively) and were matched by time to 1690 control knees.
Cases were slightly older, more likely to be female, and had higher
body mass index (Table I). On entry to the OAI cohort, cases were
more likely than controls to have a KellgreneLawrence Grade 1
score, to report previous exposure to lifting or moving objects 25
pounds on most days, and previous knee surgery (Table I).
Numbers and percentages with at least 1 item in subscale
recorded as moderate/severe/extreme (for subscales) or reporting
moderate/severe/extreme symptoms (for individual items) are
given in Web Table S1.
Data on candidate prodromal symptoms were well completed;
only 2 out of 40 outcome variables had >10%missing data at a given
time point. These were ‘difﬁculty getting in/out of the bathtub’
(15e30% missing), and ‘pain when twisting/pivoting on the knee’
(4e12% missing). Generally, the missing rate was similar for casesTable I
Characteristics of cases and controls at baseline (t0) and frequency of eligibilit
America, 2004e2010
Characteristicsy
Sex (Female)
Age in years; mean (SD)
BMI in kg/m2; mean (SD)
Eligibility factorsz
KellgreneLawrence grade 1
Above cut-off for overweight
Frequent knee bending activity
Climb 10 ﬂights, on most days
Kneel 30 min, on most days
Squat or deep knee bend 30 min, on most days
Lift or move objects 25lbs, on most days
Immediate family had knee replacement
Hard bumps on joints closest to ﬁngertips
Medication use for knee pain
Knee injury
Knee surgery
Abbreviations: BMI, body mass index; SD, standard deviation.
* Values are Number (%) unless otherwise stated.
y Measured at t0.
z Measured on entry into the OAI cohort.and controls, but the total subscale non-response tended to be
slightly higher in controls than cases, particularly at t0.Prodromal symptoms
On unadjusted univariable analysis, all WOMAC and KOOS
subscales, 31 of 34 dichotomised individual items reported at t0-1
(i.e., one year before incident ROA was ﬁrst recorded among cases)
and pain on most days were associated with outcome (P < 0.05)
(Web Table S1). Frequent awareness of a problem with the knee,
frequent knee pain, and pain on most days of at least one month in
the past 12 months were the commonest symptoms associated
with outcome (frequency among cases 54.9%, 35.8%, and 27.6%
respectively). Items with strong crude associations at t0-1 and
relatively high frequency included pain walking on a ﬂat surface
(odds ratio 5.13: 95% CI 2.97, 8.86; frequency among cases 11.6%)
and self-reported swelling of the knee (4.12: 2.23, 7.61; 9.4%).Modelling the prodromal period
From multi-level models, the estimated length of prodrome e
taken as the point at which the probability of scoring at least 1 item
in the subscale as moderate/severe/extreme were equal for cases
and controls e ranged from almost 29 months for the KOOS Other
Symptoms (Table II) to 37 months for the WOMAC Pain (Fig. 1). For
dichotomised individual items, the estimated length of prodromee
deﬁned as the point when the estimated probability of that
symptom being moderate/severe/extreme was equal for cases and
controls e ranged from 24 months (difﬁculty with light domestic
chores) to 47 months (difﬁculty taking off socks/stockings). Fig. 2
illustrates 4 examples of items with contrasting changes in the
probabilities of the cases having the symptom. The 95% conﬁdence
intervals for the estimated length of prodrome crossed zero for an
additional ﬁve individual items not displayed in Table II (difﬁculty
descending stairs, difﬁculty standing, difﬁculty walking, difﬁculty
with heavy domestic chores and pain on straightening the knee
fully). At each level, only random intercept models were ﬁtted, as
when random slope models were ﬁtted, the variance around the
slope was consistently not signiﬁcantly different from zero. There
was little difference to the overall shape of the growth model wheny factors on enrolment into the study, data from the OAI, United States of
Cases* (n ¼ 169) Controls* (n ¼ 1690)
117 (69.2) 993 (58.8)
65.2 (9.2) 64.5 (9.6)
29.2 (4.6) 27.2 (4.6)
122 (72.2) 494 (23.2)
58 (34.3) 421 (24.9)
129 (77.3) 1204 (72.0)
94 (56.6) 954 (57.0)
17 (10.1) 203 (12.1)
22 (13.0) 226 (13.5)
73 (43.5) 575 (34.4)
25 (15.0) 277 (16.6)
59 (35.1) 604 (35.9)
23 (13.6) 203 (12.0)
72 (42.6) 658 (39.2)
35 (20.7) 229 (13.6)
Table II
Coefﬁcients and estimated lengths of prodromes from multi-level models ﬁtted to subscale scores and individual items, data from the OAI, United States of America,
2004e2010
Multi-level model Estimated length of prodrome (months)
Caseecontrol status Time Interaction
b# 95% CI b** 95% CI byy 95% CI Length 95% CI
Subscale scoreszz
WOMAC Pain 1.18 0.77, 1.60 0.05 0.14, 0.04 0.38 0.64, 0.13 37.1 17.0, 57.1
WOMAC Stiffness 1.34 0.90, 1.79 0.06 0.04, 0.16 0.55 0.82, 0.27 29.6 17.5, 41.6
WOMAC Physical Function 1.08 0.67, 1.48 0.01 0.07, 0.10 0.38 0.61, 0.14 34.4 17.0, 51.8
KOOS Pain 1.32 0.96, 1.68 0.01 0.07, 0.06 0.53 0.74, 0.32 29.7 20.4, 39.0
KOOS Other Symptoms 1.08 0.70, 1.46 0.03 0.10, 0.04 0.45 0.67, 0.24 28.7 17.6, 39.8
Individual itemsxx (in ascending order of estimated length of prodrome)
Difﬁculty taking off socks/stockingsz 1.86 1.00, 2.73 0.05 0.19, 0.29 0.47 1.00, 0.05 47.1 2.3, 91.8
Pain on stairs* 1.08 0.62, 1.53 0.09 0.19, 0.01 0.32 0.60, 0.04 40.0 11.2, 68.8
Pain on twisting/pivotingx 1.41 0.89, 1.92 0.09 0.22, 0.03 0.44 0.78, 0.10 38.5 13.3, 63.8
Pain on bending knee fullyx 1.29 0.75, 1.84 0.13 0.27, 0.00 0.40 0.77, 0.04 38.4 9.1, 67.7
Difﬁculty putting on socks/stockingsz 1.77 0.97, 2.58 0.18 0.01, 0.37 0.58 1.05, 0.10 36.9 11.2, 62.7
Pain walking on ﬂat surface* 1.59 0.99, 2.20 0.02 0.17, 0.14 0.54 0.95, 0.13 35.4 12.6, 58.3
Pain when sitting or lying down* 1.15 0.40, 1.91 0.06 0.11, 0.23 0.39 0.87, 0.08 35.4 0.4, 70.5
Swellingk 1.58 0.95, 2.21 0.12 0.29, 0.05 0.55 0.98, 0.11 34.6 10.7, 58.6
Stiffness later in dayy 1.09 0.59, 1.60 0.02 0.09, 0.13 0.40 0.70, 0.09 33.2 12.0, 54.4
Difﬁculty rising from sittingz 1.13 0.58, 1.68 0.02 0.14, 0.10 0.41 0.76, 0.07 32.7 9.6, 55.8
Difﬁculty bending to ﬂoorz 0.88 0.38, 1.38 0.02 0.12, 0.08 0.33 0.63, 0.03 32.4 8.1, 56.6
Difﬁculty getting in/out of carz 1.05 0.48, 1.61 0.06 0.06, 0.17 0.40 0.74, 0.06 31.3 9.0, 53.7
Difﬁculty lying in bedz 1.69 0.96, 2.42 0.08 0.10, 0.27 0.68 1.18, 0.18 29.8 10.9, 48.7
Frequent awareness of a problem with knee¶ 0.75 0.44, 1.07 0.08 0.03, 0.13 0.30 0.47, 0.14 29.7 16.9, 42.6
Pain at night while in bed* 1.47 0.82, 2.13 0.06 0.10, 0.22 0.60 1.05, 0.15 29.7 11.0, 48.5
Knee catch or hang up when movingk 1.09 0.48, 1.69 0.02 0.11, 0.14 0.44 0.81, 0.07 29.6 8.5, 50.7
Stiffness in morningy 1.11 0.62, 1.60 0.07 0.02, 0.17 0.45 0.74, 0.16 29.5 13.6, 45.4
Frequent knee painx 1.10 0.76, 1.43 0.00 0.06, 0.06 0.45 0.65, 0.26 28.9 18.7, 39.1
Difﬁculty shoppingz 1.35 0.57, 2.14 0.02 0.20, 0.17 0.57 1.10, 0.04 28.5 5.0, 52.1
Pain on most days 1.41 1.04, 1.77 0.04 0.12, 0.03 0.60 0.84, 0.36 28.2 18.8, 37.6
Difﬁculty getting out of bedz 1.32 0.63, 2.02 0.04 0.10, 0.19 0.56 0.99, 0.14 28.1 9.2, 47.1
Difﬁculty ascending stairsz 0.96 0.42, 1.50 0.08 0.20, 0.04 0.42 0.78, 0.05 27.6 7.4, 47.8
Difﬁculty getting in/out of bathtubz 1.66 0.94, 2.38 0.12 0.05, 0.28 0.75 1.25, 0.25 26.6 11.3, 41.9
Difﬁculty sittingz 1.55 0.67, 2.42 0.01 0.24, 0.21 0.73 1.40, 0.05 25.5 4.7, 46.3
Pain on standing* 1.39 0.64, 2.14 0.01 0.18, 0.17 0.68 1.21, 0.14 24.7 7.2, 42.2
Difﬁculty with light domestic choresz 1.48 0.63, 2.33 0.02 0.19, 0.23 0.73 1.37, 0.10 24.3 5.5, 43.0
Abbreviations: CI, conﬁdence interval; WOMAC, Western Ontario and McMaster Universities Arthritis Index.
Parent scale for individual items.
* WOMAC Pain.
y WOMAC Stiffness.
z WOMAC Function.
x KOOS Pain.
k KOOS Other symptoms.
¶ KOOS Quality of Life.
# Coefﬁcient from multi-level models for caseecontrol status.
** Coefﬁcient from multi-level models for time (measured continuously in years).
yy Coefﬁcient from multi-level models for the interaction between caseecontrol status and time.
zz Modelled using multi-level linear regression models.
xx Modelled using multi-level logistic regression models.
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and so the simpler model whereby time was linear was ﬁtted.
Sensitivity analysis
Whenwe used only the ﬁrst knee to develop ROA to deﬁne cases
and selected controls from those free of ROA at the end of follow-up
(i.e., at 4 year follow-up in OAI), the estimated strengths of asso-
ciation between prodromal symptoms at t0-1 and outcome were
similar to those estimated when using concurrent sampling, but
the conﬁdence intervals were slightly narrower. The estimated
lengths of prodrome were slightly shorter than those estimated in
the primary analysis using concurrent sampling (Web Table S2).
Discussion
In this exploratory study, the incidence of ROA was associated
with a prior trajectory of increasing knee pain, stiffness, and difﬁ-
culties with functional tasks. Consistent with the generallyfavourable long-term trajectory of knee pain with minimal osteo-
arthritis26,27, control knees which did not develop ROA exhibited,
on average, no change in symptoms over the 4-year study period.
We estimated that the symptom trajectory of cases began to
diverge from control knees generally between 25 and 30 months
before the outcome of incident ROA.
Perceived difﬁculty due to the knee in taking off sock/stockings,
knee pain on twisting and pivoting, and knee joint stiffness were
among the symptoms that appeared earliest. The ﬁnding that self-
reported swelling was also more common in this prodromal phase
is intriguing. The validity of this marker as an indicator of the
presence and degree of underlying joint inﬂammation is unknown.
Yet in spite of likely random misclassiﬁcation28 this observed as-
sociationmay be consistent with effusion synovitis (but not cysts29)
predicting future cartilage loss reported in recent magnetic reso-
nance imaging studies30e32.
A prodrome is deﬁned as “an early symptom indicating the
onset of a disease or illness”33. The outcome in the present study e
the new onset of combined deﬁnite osteophyte and joint space
0
.0
4
.0
8
.1
2
.1
6
.2
P
ro
ba
bi
lit
y
-48 -36 -24 -12 0
Time, months
WOMAC Pain
Fig. 1. Probability of cases (solid line, diamond marker) and controls (dashed line,
triangle marker) responding moderate, severe or extreme to at least 1 item in the
WOMAC pain subscale at each time prior to t0 (incidence for the cases)estimated from
multi-level model. The length of the prodrome is estimated as the time point where
these lines cross. Data from the OAI, United States of America, 2004e2010.
R. Case et al. / Osteoarthritis and Cartilage 23 (2015) 1083e1089 1087narrowing in the tibiofemoral jointe is neither the beginning of the
pathological process of osteoarthritis nor even the ﬁrst indication
from plain radiographs of gross morphological changes. The
appearance of ‘doubtful osteophytes’ (KellgreneLawrence Grade I)
strongly predicts the outcome used in our study34e36. There were
only 117 incident Grade I cases in the ﬁrst four years of follow-up in
the OAI cohort but we would also defend our choice of a more
advanced stage of disease on the grounds that it permits direct
comparison of ﬁndings with other studies using the same outcome
to investigate early disease biomarkers (e.g.,17) and that it may be
more strongly associated with symptoms37. While Kellgren &
Lawrence Grade I changes on plain radiographs were strongly
associated with the outcome of future deﬁnite osteophyte and joint0
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Fig. 2. Probability of cases (solid line, diamond marker) and controls (dashed line, triangle m
t0 (incidence for the cases). The length of the prodrome is estimated as the time point whspace narrowing (data not shown), the persistence of an association
between prodromal symptoms and outcome after adjusting for
Grade I implies that the pathologic process represented by transi-
tion from doubtful to deﬁnite osteophyte cannot fully explain the
existence of prodromal symptoms. These arguments illustrate the
difﬁculties in applying the concept of a prodrome to a pathological
disease process that does not have an unambiguously deﬁned
discrete point of onset, which comprises repair and damage pro-
cesses, and in which new imaging modalities and biomarkers are
redeﬁning ‘early disease’38. A critical assumption in our study is
that the new onset of combined deﬁnite osteophyte and joint space
narrowing represents a meaningful and important stage in the
osteoarthritic process39, but in some cases radiological changes
might not be the ﬁrst sign of the disease, as symptoms can be
present without radiological changes, and this may constitute ‘real
disease’. The methods used in our study could be applied to explore
prodromal symptoms at other putative stages in that process.
The OAI is the largest suitable dataset for this study with the
advantage of participants selected to be at high risk of future
incident ROA. Nevertheless, there were only a small number of
incident cases over the 4-year follow-up. We conﬁrmed on quali-
tative inspection that there were no major differences in the
strength or direction of the associations when the observations
were split into four mutually exclusive groups dependent on the
study visit that was assigned as the baseline time (i.e., t0 at 1 year, 2
year, 3 year or 4 year follow up visit). This was investigated to rule
out any effect of regression to the mean after unusually high
measurements at the ﬁrst OAI visit related to selection into the
cohort in our analysis. As a result of the small number of incident
cases, estimates for the length of the prodrome are quite imprecise
and it was not possible to quantitatively explore different patterns
of prodromal symptoms among cases. It was also necessary to
dichotomise the ordinal responses to individual items which will
have resulted in a loss of information. For all items we chose a
standard cut-point, a priori, corresponding towhat we feel may be a
meaningful distinction between ‘mild’ and ‘moderate’ severity and
which we have used previously40. The annual intervals between0
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arker) responding moderate, severe or extreme to individual items at each time prior to
ere these lines cross. Data from the OAI, United States of America, 2004e2010.
R. Case et al. / Osteoarthritis and Cartilage 23 (2015) 1083e10891088repeated measures of symptoms also limit the ability to ﬁt the
actual timing of prodromal symptom change, including non-linear
trajectories. It is also worth stressing that in conducting this nested
caseecontrol study within a cohort of ‘high risk’ patients, the
length of prodrome is likely to be under-estimated relative to a
study conducted in an unselected population sample.
The association between prodromal symptoms and the
outcome of radiographic evidence of osteophytes and joint space
narrowing is hypothesized to result from a shared common cause:
pathologic tissue damage that is part of the underlying osteoar-
thritic process and that acts as a peripheral nociceptive driver.
Adjusting for covariates that are believed to cause this disease
process e for example, high body mass index, prior signiﬁcant
injury or surgery to the knee, and a family history of osteoarthritis
e is not indicated. Our ﬁndings of a prodrome for incident
radiographic knee OA are adjusted for potential confounding by
age and gender. Future larger studies may be able to investigate
hypothesized causal mechanisms that give rise to the observed
prodromal symptoms.
The mean scores on WOMAC subscales in this population are
very low, the differences between cases and controls small, and
each prodromal symptom was reported by 5e20% of cases in the
prodromal phase. While these ﬁndings are comparable with those
from studies of early imaging biomarkers in the same cohort, they
emphasize the need for multivariable models for individual risk
prediction as well as the continued need for measurements that are
more sensitive to change in symptoms in the early stages of disease.
It is worth noting that a fairly large proportion of the cases had no
symptoms at the time of incidence (44% had a WOMAC Pain sub-
scale score of zero at t0).
In conclusion, we have studied the nature and timing of
symptoms preceding the incidence of ROA and found a trajectory of
increasing pain, stiffness, and functional limitation that appears to
begin, on average, at least two to three years before this disease
stage is reached. This does not mark the beginning of the osteoar-
thritic process but may be related to phasic progression of the
condition. The value of prodromal symptoms in helping target early
intervention may warrant further investigation.Author contributions
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